BCL2 and B-cell chronic lymphocytic leukemia: Common medications used to treat newly diagnosed and relapsed/refractory chronic lymphocytic leukemia (CLL) include Bruton tyrosine kinase inhibitors (BTKi) and B-cell lymphoma-2 inhibitors (BCL-2).